HemaSphere
(Jun 2022)
P1744: ACCURACY OF PREDICTING LONG-TERM SURVIVAL OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPIES IN LARGE B-CELL LYMPHOMA (LBCL)
- E. J. Verburg-Baltussen,
- A. Stewart,
- F. F. Liu,
- C. Parker,
- E. F. Peterse,
- M. Treur,
- B. Malcolm,
- S. Klijn
Affiliations
- E. J. Verburg-Baltussen
- 1 OPEN Health, Rotterdam, Netherlands
- A. Stewart
- 2 OPEN Health, Oxford, United Kingdom
- F. F. Liu
- 3 Bristol Myers Squibb, Princeton, United States of America
- C. Parker
- 4 Bristol Myers Squibb, Uxbridge, United Kingdom
- E. F. Peterse
- 1 OPEN Health, Rotterdam, Netherlands
- M. Treur
- 1 OPEN Health, Rotterdam, Netherlands
- B. Malcolm
- 4 Bristol Myers Squibb, Uxbridge, United Kingdom
- S. Klijn
- 3 Bristol Myers Squibb, Princeton, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000849832.54477.ed
- Journal volume & issue
-
Vol. 6
pp.
1625
– 1626
WeChat QR code